Trials / Completed
CompletedNCT02798380
Efficacy, Safety, and Tolerability of HTS-519 Insert in Patients With Toenail Fungus of the Big Toenail
An Open-Label Phase 2 Study to Investigate the Efficacy, Tolerability, and Safety of the HTS-519 Insert in the Treatment of Subjects With Distal Lateral Subungual Onychomycosis of the Great Toenail
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Hallux, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy, safety and tolerability of HTS-519 Inserts in the treatment of mild to moderate toenail fungus disease of the big toenail.
Detailed description
Open label, single-site
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HTS-519 Insert | Maximum feasible dose of HTS-519 Insert per diseased nail |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2018-10-01
- Completion
- 2018-10-01
- First posted
- 2016-06-14
- Last updated
- 2021-11-02
- Results posted
- 2019-09-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02798380. Inclusion in this directory is not an endorsement.